Suppr超能文献

单次注射脂质体布比卡因可减少门诊肩袖修复术后阿片类药物的使用:一项前瞻性、双盲、随机对照试验。

Single-Shot Liposomal Bupivacaine Reduces Postoperative Narcotic Use Following Outpatient Rotator Cuff Repair: A Prospective, Double-Blinded, Randomized Controlled Trial.

机构信息

Indiana University School of Medicine, Indianapolis, Indiana.

Department of Medical and Population Health Sciences Research, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.

出版信息

J Bone Joint Surg Am. 2020 Nov 18;102(22):1985-1992. doi: 10.2106/JBJS.20.00225.

Abstract

BACKGROUND

Liposomal bupivacaine (LB) theoretically is longer-acting compared with conventional bupivacaine. The purpose of this study was to compare conventional bupivacaine combined with dexamethasone (control group), LB combined with conventional bupivacaine (LB group), and LB combined with dexamethasone and conventional bupivacaine (LBD group) in a perineural interscalene nerve block during ambulatory arthroscopic rotator cuff repair to determine if LB decreased postoperative narcotic consumption and pain. The effect of supplemental dexamethasone on prolonging the analgesic effect of LB was also assessed.

METHODS

This was a prospective, double-blinded, randomized controlled trial of 76 consecutive patients who underwent outpatient arthroscopic rotator cuff repair. Patients were randomized into the 3 interscalene-block treatment groups: control group (n = 26), LB group (n = 24), and LBD group (n = 26). Outcome measures included pain measured with a visual analog scale (VAS; 0 to 10) and narcotic consumption measured in oral morphine milligram equivalents (MME). Both were measured daily on postoperative day 0 through postoperative day 4.

RESULTS

Generalized estimating equation modeling revealed that narcotic consumption across all time points (postoperative days 0 to 4) was significantly lower in the LB group compared with the control group (mean difference, -8.5 MME; 95% confidence interval, -15.4 to -1.6; p = 0.015). Narcotic consumption was significantly higher in the control group on postoperative days 2 and 3 compared with the LB group (p = 0.004 and p = 0.02, respectively) and the LBD group (p = 0.01 and p = 0.003, respectively). There was no difference in narcotic consumption between the LBD and LB groups on any postoperative day. VAS pain scores in all groups were similar across all postoperative days.

CONCLUSIONS

Among patients undergoing outpatient arthroscopic rotator cuff repair, the addition of LB to conventional bupivacaine in interscalene nerve blocks appeared to be effective in controlling postoperative pain. Because LB with and without dexamethasone decreased postoperative narcotic use, LB should be considered for use in preoperative interscalene nerve blocks to reduce the reliance on narcotics for pain management.

LEVEL OF EVIDENCE

Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

摘要

背景

与传统布比卡因相比,脂质体布比卡因(LB)的作用时间理论上更长。本研究旨在比较在门诊关节镜肩袖修复中应用常规布比卡因联合地塞米松(对照组)、LB 联合常规布比卡因(LB 组)和 LB 联合地塞米松和常规布比卡因(LBD 组)的经神经周围肌间沟神经阻滞,以确定 LB 是否能减少术后阿片类药物的消耗和疼痛。还评估了补充地塞米松对延长 LB 镇痛效果的影响。

方法

这是一项前瞻性、双盲、随机对照试验,纳入了 76 例连续接受门诊关节镜肩袖修复的患者。患者随机分为 3 组肌间沟阻滞治疗组:对照组(n=26)、LB 组(n=24)和 LBD 组(n=26)。观察指标包括术后 0 至 4 天每天用视觉模拟评分(VAS;0 至 10)和口服吗啡毫克当量(MME)测量的疼痛。

结果

广义估计方程模型显示,与对照组相比,LB 组在所有时间点(术后 0 至 4 天)的阿片类药物消耗明显更低(平均差值,-8.5 MME;95%置信区间,-15.4 至-1.6;p=0.015)。LB 组术后第 2 天和第 3 天的阿片类药物消耗明显高于对照组(p=0.004 和 p=0.02)和 LBD 组(p=0.01 和 p=0.003)。LBD 组和 LB 组在任何术后日的阿片类药物消耗均无差异。所有组的 VAS 疼痛评分在所有术后日均相似。

结论

在接受门诊关节镜肩袖修复的患者中,LB 联合常规布比卡因用于肌间沟神经阻滞似乎能有效控制术后疼痛。由于 LB 联合和不联合地塞米松均可减少术后阿片类药物的使用,因此应考虑在术前肌间沟神经阻滞中使用 LB,以减少对阿片类药物的依赖来进行疼痛管理。

证据水平

治疗性 I 级。请参阅作者指南,以获取完整的证据水平描述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验